For in-vitro research use only. Not for human consumption.
CJC-1295 With DAC
CJC-1295 with DAC is a synthetic GHRH analog conjugated with a Drug Affinity Complex that covalently binds serum albumin, dramatically extending its research half-life. This produces sustained GH elevation rather than the pulsatile pattern seen with the non-DAC version.
CJC-1295 With DAC definition
CJC-1295 with DAC is a synthetic GHRH analog conjugated with a Drug Affinity Complex that covalently binds serum albumin, dramatically extending its research half-life. This produces sustained GH elevation rather than the pulsatile pattern seen with the non-DAC version.
No sequence is listed in the current catalog record for this product.
- CAS
- 446262-90-4
- MW
- 3647.30 Da (with DAC conjugate)
- Sequence
- Not listed
- Half-life
- Discussed in research notes
- Formula
- C165H269N47O46
- Purity
- 99.71%
- Form
- Lyophilized powder
- Class
- Long-Acting GHRH Analog
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- CAS Number
- 446262-90-4
- Molecular Weight
- 3647.30 Da (with DAC conjugate)
- Molecular Formula
- C₁₆₅H₂₆₉N₄₇O₄₆
- Class
- Long-Acting GHRH Analog
- Purity
- ≥99% purity
- Physical Form
- Lyophilized powder
- Storage
- Store at -20°C (long term). Refrigerate after reconstitution.
Research context.
The DAC technology was developed to study prolonged GHRH receptor stimulation. Published pharmacokinetic studies have characterized its extended duration of action compared to native GHRH and Mod GRF 1-29. Useful for research protocols requiring sustained rather than pulsatile GH signaling.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
CJC-1295 With DAC is part of the Nexus Growth Hormone Secretagogues catalog. GHRH analogs, GH secretagogues, and growth-factor research compounds. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
30-amino acid GHRH analog conjugated with a Drug Affinity Complex (DAC) for albumin binding
Storage: Store at -20°C (long term). Refrigerate after reconstitution.
Technical specifications.
- Product Name: CJC-1295 with DAC
- Classification: Long-Acting GHRH Analog
- Structural Description: 30-amino acid GHRH analog conjugated with a Drug Affinity Complex (DAC) for albumin binding
- CAS Number: 446262-90-4
- Molecular Weight: 3647.30 Da (with DAC conjugate)
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
CJC-1295 With DAC research FAQ.
What is CJC-1295 With DAC used for in research?
CJC-1295 With DAC is supplied for controlled in-vitro research workflows in the Growth Hormone Secretagogues category. It is not labeled for human or veterinary use.
Is CJC-1295 With DAC HPLC verified?
CJC-1295 With DAC is listed with Nexus lab verification. Current catalog records show 99.71% purity context where batch COA data is available.
Which CJC-1295 With DAC sizes are available?
Current Nexus variants include 2mg, 5mg, 10mg.
Does CJC-1295 With DAC include a COA?
Yes. The current Nexus record links CJC-1295 With DAC to batch NEX-CJC-1295-WITH-DAC-2026-0025.